Novelli, P. M., Zureikat, A. H., Pishvaian, M. J., Meredith, K., Hatoum, H., Zervos, E. E., Nazemzadeh, R., Laroia, S., Kasi, P. M., Agah, R. (2026). Intra-arterial gemcitabine versus intravenous gemcitabine: Pharmacokinetic and pharmacodynamic sub-study of the TIGeR-PaC phase 3 clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.732